Literature DB >> 30159979

Measurement of cerebrospinal fluid orexin-A (hypocretin-1) by enzyme-linked immunosorbent assay: A comparison with radioimmunoassay.

Taisuke Ono1, Takashi Kanbayashi1,2, Kazuhisa Yoshizawa1, Seiji Nishino3, Tetsuo Shimizu1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30159979     DOI： 10.1111/pcn.12780

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN： 1323-1316            Impact factor:   5.188


× No keyword cloud information.
  8 in total

1.  A false alarm of narcolepsy: obstructive sleep apnea masquerading as narcolepsy and vice-versa: two further controversial cases.

Authors:  A Romigi; M Caccamo; G Vitrani; F Testa; C Nicoletta; A C Sarno; B Di Gioia; D Centonze
Journal:  Sleep Breath       Date:  2020-04-15       Impact factor: 2.816

2.  Reduced CSF orexin levels in rats and patients with systemic inflammation: a preliminary study.

Authors:  Yasuhiro Ogawa; Nobutake Shimojo; Akiko Ishii; Akira Tamaoka; Satoru Kawano; Yoshiaki Inoue
Journal:  BMC Res Notes       Date:  2022-06-25

3.  Plasma Orexin-A Levels in Patients With Schizophrenia: A Systematic Review and Meta-Analysis.

Authors:  Shaoli Li; Ruili Zhang; Shaohua Hu; Jianbo Lai
Journal:  Front Psychiatry       Date:  2022-05-25       Impact factor: 5.435

4.  Hypocretin-1 measurements in cerebrospinal fluid using radioimmunoassay: within and between assay reliability and limit of quantification.

Authors:  Adrienne Elisabeth van der Hoeven; Kevin van Waaij; Denise Bijlenga; Frederik Willem Cornelis Roelandse; Sebastiaan Overeem; Jaap Adriaan Bakker; Rolf Fronczek; Gert Jan Lammers
Journal:  Sleep       Date:  2022-07-11       Impact factor: 6.313

5.  HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy.

Authors:  Noriaki Sakai; Mari Matsumura; Ling Lin; Emmanuel Mignot; Seiji Nishino
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

6.  Sleep modulates haematopoiesis and protects against atherosclerosis.

Authors:  Cameron S McAlpine; Máté G Kiss; Sara Rattik; Shun He; Anne Vassalli; Colin Valet; Atsushi Anzai; Christopher T Chan; John E Mindur; Florian Kahles; Wolfram C Poller; Vanessa Frodermann; Ashley M Fenn; Annemijn F Gregory; Lennard Halle; Yoshiko Iwamoto; Friedrich F Hoyer; Christoph J Binder; Peter Libby; Mehdi Tafti; Thomas E Scammell; Matthias Nahrendorf; Filip K Swirski
Journal:  Nature       Date:  2019-02-13       Impact factor: 49.962

7.  Cerebrospinal fluid orexin in Alzheimer's disease: a systematic review and meta-analysis.

Authors:  Spencer P Treu; David T Plante
Journal:  Sleep Med       Date:  2021-07-13       Impact factor: 4.842

8.  Risk of immunotherapy-related narcolepsy in genetically predisposed patients: a case report of narcolepsy after administration of pembrolizumab.

Authors:  Yutaka Natori; Eisaku Sasaki; Shu Soeda; Shigenori Furukawa; Yusuke Azami; Emi Tokuda; Takashi Kanbayashi; Shigehira Saji
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.